Session » Metabolic & Crystal Arthropathies – Basic & Clinical Science Poster I (0660–0682)
-
Abstract Number: 0660
Improving the Gout Flare Chart Review Using Linked Claims-EHR Data
-
Abstract Number: 0661
Effect of Omega-three Supplementation on Serum Urate and Gout Flares in People with Gout; A Pilot Randomized Trial
-
Abstract Number: 0662
Serum Urate Reduction Is Causally Associated with Flare Outcomes in People with Gout: Evidence for Surrogate Status from a Pooled Analysis of 2 Randomized Trials
-
Abstract Number: 0663
Disappearing Digits: A National Retrospective Matched Cohort Study Examining the Risk of Lower Extremity Amputation in Gout
-
Abstract Number: 0664
Which Attributes Are the Most and Least Important to Patients When Considering Gout Flare Burden over Time? A Best-worst Scaling Choice Study
-
Abstract Number: 0665
Pegloticase Treatment for Uncontrolled Gout in Kidney Transplanted Patients: Results of an On-going Multicenter, Open-Label, Efficacy and Safety Study
-
Abstract Number: 0666
Process Mapping Gout Hospitalizations: A Deep Dive into an Avoidable Epidemic
-
Abstract Number: 0667
Active Screening for Gout Permits Identifying a Larger Cardiovascular Population at High Mortality Risk
-
Abstract Number: 0668
Patient Perspectives and Preferences Regarding Gout and Gout Management: Impact on Adherence
-
Abstract Number: 0669
Early-Onset Gout (EOG) Patients Are an Important and Recalcitrant Phenotype Warranting Further Investigation: A Systematic Review
-
Abstract Number: 0670
Hemochromatosis Is Associated with CPPD Through Iron’s Effect on Bone
-
Abstract Number: 0671
Concomitant Immunomodulation and Pegloticase Therapy: Experiences with a Variety of Immunomodulatory Agents in Two Community Rheumatology Practices
-
Abstract Number: 0672
Does Obesity Affect Gout Risk Differently Among Genetically Predisposed Individuals?: Sex-Specific Prospective Cohort Study Findings over >32 Years
-
Abstract Number: 0673
The Impact of Allopurinol on Blood Pressure and Renal Outcome in Gout Patients: A Retrospective Study
-
Abstract Number: 0674
A Behavioral Intervention to Improve Gout Outcomes in African Americans with Gout: A 12-month Multicenter, Randomized Controlled Trial
-
Abstract Number: 0675
Urate-lowering Therapy for Prevention of Gout: Prespecified Analyses from the CKD-FIX Trial
-
Abstract Number: 0676
Development, Refinement, and Validation of an Emergency Department Gout Flare Electronic Medical Record Alert
-
Abstract Number: 0677
Pro-Inflammatory Diet and Increased Risk of Incident Female Gout: 30-Year Prospective Cohort Study of >170,000 Pre- and Post-Menopausal US Women
-
Abstract Number: 0678
Is There a Difference in Self-reported Flare Frequency Between Men and Women?
-
Abstract Number: 0679
Cardiovascular Risk Associated with Treatment of Allopurinol and Benzbromarone in Patients with Gout
-
Abstract Number: 0680
Gout Stigma: Investigating the Existence of Gout Stigma and Its Impact on Patient Perceptions and Treatment Decisions